News
Amryt and Medison Pharma Ltd sign distribution agreement for Myalept in Canada.
Amryt announces the signing of a distribution agreement with Medison Pharma Canada (“Medison”) to distribute Myalept (metreleptin) in Canada. This agreement completes the multi-regional distribution agreements with Medison, announced in February, to distribute Myalept (metreleptin) and Lojuxta (lomitapide) in Israel, and Juxtapid (lomitapide) in Canada.
This agreement completes the multi-regional distribution agreements with Medison, announced in February, to distribute Myalept (metreleptin) and Lojuxta (lomitapide) in Israel, and Juxtapid (lomitapide) in Canada.
Condition: Lipodystrophy
Type: drug